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Microbial transformation was carried out on three natural product compounds, namely 
zerumbone, goniothalamin and cardamonin, using the fungi Aspergillus niger and 
Sclerotium rolfsii. Aspergillus niger and Sclerotium rolfsii have successfully converted 
zerumbone into two products, namely 2,3-dihydrozerumbone and 6,7-epoxyzerumbone. 
Aspergillus niger and Sclerotium rolfsii also successfully biotransformed goniothalamin 
into 2,3-dihydrogoniothalamin. The trial carried out on cardamonin was unsuccessful 
due to the antimicrobial activity of the compound that inhibited the growth of the fungi. 
Sclerotium rolfsii is a newly discovered biotransformer able to carry out hydrogenation 
and epoxidation.    
  
Two microbial toxins, namely gliotoxin and bisdethiobis(methylthio)gliotoxin were 
isolated in the course of biotransformation of goniothalamin using A. niger and S. rolfsii  
cultured on PKC (Palm Kernel Cake) media. The toxins were not produced when the 
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biotransformation was repeated using fungi cultured on standard glucose media.  Thus, 
PKC was deduced to be conducive to the production of the toxins by the two fungi. 
 
In an attempt to isolate and purify marchantin A as a candidate for biotransformation 
studies, several compounds which included marchantin A, apigenin, luteolin and a 
mixture of stigmasterol and β-sitosterol were found.. 
 
A preliminary antiinflammatory and anticholinesterase activities screening of the 
isolated compounds (zerumbone, 2,3-dihydrozerumbone, 6,7-epoxyzerumbone, 
goniothalamin, 2,3-dihydrogoniothalamin, gliotoxin, bisdethiobis(methylthio)gliotoxin, 
apigenin, luteolin, marchantin A and mixture of β-sitosterol and stigmasterol, were also 
conducted. Luteolin exhibited strong inhibition of soybean lipoxygenase with an IC50 
value of  6.25 μg/ml while zerumbone showed moderate inhibition against soybean 
lipoxygenase with an IC50 value of 22.83 μg/ml. The other compounds were inactive 
towards the enzyme.   In the anticholinesterase inhibitory assay, zerumbone,  6,7-
epoxyzerumbone, marchantin A, goniothalamin, apigenin and luteolin, as well as a 
mixture of β-sitosterol and stigmasterol were found to inhibit the enzyme. 
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Transformasi Mikrob telah dijalankan terhadap tiga sebatian semulajadi yang dipilih 
iaitu, zerumbone, goniothalamin, dan cardamonin  dengan menggunakan Aspergillus 
niger dan Sclerotium rolfsii. Aspergillus niger dan Sclerotium roflsii berjaya 
mentransformasi zerumbone kepada dua hasil, iaitu 2,3-dihydrozerumbone dan 6,7-
epoksizerumbone. Transformasi mikrob Aspergillus niger dan Sclerotium rolfsii juga 
berjaya menukarkan goniothalamin kepada 2,3-dihydrogoniothalamin. Kajian terhadap 
cardamonin tidak berjaya disebabkan oleh kesan antifungi yang terdapat dalam sebatian 
tersebut. Sclerotium rolfsii dikesan sebagai agen biotransformasi yang berpotensi untuk 
dikaji dalam transformasi mikrob. 
 
Dua sebatian toksik mikrob, iaitu gliotoxin dan bisdethiobis(methylthio)gliotoxin telah 
dipencilkan daripada transformasi Aspergillus niger terhadap goniothalamin yang 
difermentasi dalam Palm Kernal Cake (PKC). Toksin mikrob ini didapati tidak 
 vi 
dihasilkan semula apabila kaedah transformasi mikrob diulangi dengan fungi yang 
dikultur dalam media asas. Oleh yang demikian, PKC dapat dicadangkan sebagai media 
yang kondusif untuk menghasilkan toksin mikrob tersebut dengan menggunakan fungi 
ini.   
 
Dalam percubaan untuk memencilkan dan mengasingkan marchantin A sebagai calon 
dalam kajian biotransformasi, beberapa sebatian termasuk marchantin A, apigenin, 
luteolin dan campuran β-sitosterol dan stigmasterol telah ditemui. 
 
Kajian awal aktiviti antioksidan dan antikolinesterase telah dijalankan secara teliti 
terhadap sebelas sebatian kimia (zerumbon, 2,3-dihydrozerumbone, 6,7-
epoxyzerumbone, goniothalamin, 2,3-dihydrogoniothalamin, gliotoxin, 
bisdethiobis(methylthio)gliotoxin, apigenin, luteolin, marchantin A dan campuran β-
sitosterol dan stigmasterol) . Luteolin telah menunjukkan activiti yang ketara terhadap 
kesan antioksidan dengan IC50 6.25 μg/m, manakala zerumbon menunjukkan aktiviti 
perencatan yang sederhana terhadap enzim oksidan ini dengan IC50 22.83 μg/ml. 
Sebatian kimia lain didapati tidak aktif terhadap aktiviti antioksidan. Dalam aktiviti 
perencatan antikolinesterase,  zerumbon, 6,7-epoxyzerumbone, marchantin A, campuran 
β-sitosterol dan stigmasterol ,goniothalamin, apigenin dan luteolin didapati merencatkan 
enzim kolinesterase. 
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CHAPTER 1 
  
INTRODUCTION 
 
 Currently, there are increasing interests in synthetic chemistry in the search of 
new lead for drug development. Synthetic chemistry has played an important role in 
increasing an ever-growing array of complex, optically active natural products and their 
analogues. It is understandable that the stereoselective elaboration of chiral centers has 
become a central issue, especially in pharmaceutical research and drug manufacturing. 
 
In order to meet this challenge, there was an unprecedented development in the 
methodology of synthetic organic chemistry. The use of metallo-organic compounds, 
metal catalyzed homogeneous and heterogeneous catalysis, phase transfer catalysis, 
electrochemical and photochemical techniques, reagents on solid supports and other 
method have all contributed to the armory of stereoselective synthesis. At the same time, 
biotransformation via the use of enzymes and microorganisms to facilitate the reaction 
process has achieved significance most notably in the preparation of key chiral 
intermediates. 
 
Biotransformation has emerged as a new technology in the field of natural products. It is 
a method of maximizing diversity from a single chemical entity by using other 
biological systems, in the form of whole cells or isolated enzymes, to modify the 
molecule. In some cases, biotransformation has become a powerful alternative to 
conventional synthetic chemical techniques, due to their high chemo-, region- and 
 2 
stereoselectivity. More over, the ability of enzymes or microbial catalysts to perform 
difficult chemical reactions, such as hydroxylation of non-activated carbons, on 
structurally complex molecules, without the need of protection and deprotection steps of 
reactive functional groups, was recognized.  
 
There are many reasons worth trying for exploiting biotransformation in natural product 
chemistry. Firstly, biotransformation that employs microorganisms may achieve high 
selective transformation of prototype compounds leading to products which are rare, or 
only available in very low yield by traditional chemical approaches. Secondly, 
interesting new analogues of biologically active compounds may be prepared without 
resorting to new and cumbersome total synthetic chemical methods. 
 
Biotransformation encompasses the use of living organisms such as fungi, bacteria, 
microalgae, yeast and plant cell as biocatalysts. The substrate specificity of many of 
these microorganisms for bioconversion is often quite low, enabling a single organism to 
biotransform a range of related compounds with similar efficiencies. Moreover, enzymes 
that are produced by microorganisms are well known for practically every type of 
chemical reaction. There have been many examples which describe the versatility of the 
microbe in biotransforming chemical entities.  One of the earliest and most famous is the 
biotransformation of progesterone (1) to 11 α-hydroxyprogesterone (2) by Rhizopodus 
arrhizus (Figure 1). The reactions are stereospecific, the ultimate in specificity being 
amplified by such steroid bioconversions. The end-product of this biotransformation has 
been widely utilized as an intermediate in the preparation of ascorbic acid (Lehman at 
al.,  2001). 
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Figure 1. Biotransformation of progesterone to 11 α-hydroxyprogesterone 
by Rhizopodus arrhizus (Lehman et al., 2001). 
 
Lately, there have been many examples of active metabolites resulting from 
biotransformation reaction that have been developed and marketed as drug. For example, 
desloratadine or Clarinex is an anti-histamine agent 10-fold more potent than its parent 
molecule loratadine or Claritin. An active metabolite can also serve as a modified lead 
compound as exemplified by ezetimibe, a cholesterol absorption inhibitor. The drug was 
discovered as a result of structural modification of its lead candidate SCH48461, a 
biotransformed product with 40-fold more potency than its parent molecule (Fura A., 
2006). 
 
In addition, biotransformation is enjoying an increasing interest, not only in academia, 
but also in industry. The number of synthetic steps employed in classical chemical 
synthesis may be reduced to a single step by biotransformation.  This thereby, cuts off 
the occupation time of chemical reactors, which is an important factor of process 
economy in pharmaceutical and chemical production. The waste stream from 
biotransformation reactions are thus much less costly to dispose of than those of 
standard chemical techniques due to the fact that they are all environmental friendly by-
1 2 
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products. As a result, biotransformation is often considered “green chemistry” because 
of lower negative impact of this technology to the environment. 
 
Malaysia, widely-recognized as one of the centers of biological diversity, is richly 
endowed with plants, animals and microbial genetic resources. If exploited and 
managed wisely, these genetic resources could provide renewable useful products for 
not only the present but also the future generation. This study was thus carried out 
with the following objectives: 
1. to isolate and purify selected bioactive natural products as substrate for 
biotransformation, 
2. to carry out microbial transformation on the selected natural products, 
3. to elucidate the structures of the biotransformed products, and 
4. to subject the biotransformed product to selected bioassay. 
 
 
 
 
 
 
 
 
 
 
 
